Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap

Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap | Stegemann et al Read more…

Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit

Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit Building Clinical Trial and Health Research Access for People of Color via Community Health Centers (CHCs) Toolkit | Neighborhood Health Care and Altura This toolkit is a supplement to the white paper examining Read more…

Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials

Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials | Article “A recently launched peer reviewed publication in Current Breast Cancer Reports which highlights Tigerlily’s Clinical Trial capabilities. Tigerlily believe that it is critical to engage all parts of the community Read more…

IRB and HRPP Toolkit

IRB and HRPP Toolkit IRB and HRPP Toolkit | MRCT Center of Brigham and Women’s Hospital and Harvard Resources for IRBs/HRPPs to provide to Investigators/Research Teams. Includes resources on participant costs, payments to research participants, including the community voice in clinical research, incorporating DEI into Clinical Research Protocol Templates, incorporating Read more…

HealthMatch Report- Quantifying Diversity, Equity and Inclusion in Clinical Trials

HealthMatch Report: Quantifying Diversity, Equity and Inclusion in Clinical Trials HealthMatch Report: Quantifying Diversity, Equity and Inclusion in Clinical Trials A report with findings from a large clinical trial patient engagement survey. Users on the HealthMatch platform and received 7,903 responses among patients. Questions explored interactions with the health system, Read more…

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry | FDA Guidance for sponsors intended to support a new drug application or a Read more…

FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making

FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making | FDA A four-part series of Read more…

Global Investigative Site Personnel Diversity and Its Relationship with Study Participant Diversity

Global Investigative Site Personnel Diversity and Its Relationship with Study Participant Diversity Global Investigative Site Personnel Diversity and Its Relationship with Study Participant Diversity | Therapeutic Innovation & Regulatory Science Scant empirical data exists regarding the racial and ethnic demographics of professionals overseeing pharmaceutical and biotech-funded clinical trials and their Read more…

Touch, the Black Breast Cancer Alliance

Touch, the Black Breast Cancer Alliance Touch, the Black Breast Cancer Alliance Touch, The Black Breast Cancer Alliance drives the collaborative efforts of patients, survivors, advocates, advocacy organizations, health care professionals, researchers, and pharmaceutical companies to work collectively, with accountability, towards the common goal of eradicating Black Breast Cancer. Learn Read more…

Select Language »